rs180552

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005264.8(GFRA1):​c.*5067C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.39 in 152,036 control chromosomes in the GnomAD database, including 14,014 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 14012 hom., cov: 33)
Exomes 𝑓: 0.19 ( 2 hom. )

Consequence

GFRA1
NM_005264.8 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.147

Publications

5 publications found
Variant links:
Genes affected
GFRA1 (HGNC:4243): (GDNF family receptor alpha 1) This gene encodes a member of the glial cell line-derived neurotrophic factor receptor (GDNFR) family of proteins. The encoded preproprotein is proteolytically processed to generate the mature receptor. Glial cell line-derived neurotrophic factor (GDNF) and neurturin (NTN) are two structurally related, potent neurotrophic factors that play key roles in the control of neuron survival and differentiation. This receptor is a glycosylphosphatidylinositol (GPI)-linked cell surface receptor for both GDNF and NTN, and mediates activation of the RET tyrosine kinase receptor. This gene is a candidate gene for Hirschsprung disease. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]
GFRA1 Gene-Disease associations (from GenCC):
  • renal hypodysplasia/aplasia 4
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.647 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005264.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GFRA1
NM_005264.8
MANE Select
c.*5067C>T
3_prime_UTR
Exon 11 of 11NP_005255.1
GFRA1
NM_001348098.4
c.*5067C>T
3_prime_UTR
Exon 11 of 11NP_001335027.1
GFRA1
NM_001145453.4
c.*5067C>T
3_prime_UTR
Exon 10 of 10NP_001138925.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GFRA1
ENST00000355422.11
TSL:5 MANE Select
c.*5067C>T
3_prime_UTR
Exon 11 of 11ENSP00000347591.6
GFRA1
ENST00000369236.5
TSL:1
c.*5067C>T
3_prime_UTR
Exon 9 of 9ENSP00000358239.1

Frequencies

GnomAD3 genomes
AF:
0.390
AC:
59241
AN:
151896
Hom.:
13972
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.653
Gnomad AMI
AF:
0.172
Gnomad AMR
AF:
0.351
Gnomad ASJ
AF:
0.208
Gnomad EAS
AF:
0.614
Gnomad SAS
AF:
0.337
Gnomad FIN
AF:
0.282
Gnomad MID
AF:
0.341
Gnomad NFE
AF:
0.255
Gnomad OTH
AF:
0.390
GnomAD4 exome
AF:
0.192
AC:
5
AN:
26
Hom.:
2
Cov.:
0
AF XY:
0.111
AC XY:
2
AN XY:
18
show subpopulations
African (AFR)
AF:
1.00
AC:
2
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.150
AC:
3
AN:
20
Other (OTH)
AF:
0.00
AC:
0
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.390
AC:
59326
AN:
152010
Hom.:
14012
Cov.:
33
AF XY:
0.391
AC XY:
29029
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.653
AC:
27070
AN:
41448
American (AMR)
AF:
0.351
AC:
5359
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.208
AC:
721
AN:
3472
East Asian (EAS)
AF:
0.613
AC:
3144
AN:
5130
South Asian (SAS)
AF:
0.337
AC:
1626
AN:
4826
European-Finnish (FIN)
AF:
0.282
AC:
2982
AN:
10576
Middle Eastern (MID)
AF:
0.342
AC:
100
AN:
292
European-Non Finnish (NFE)
AF:
0.255
AC:
17341
AN:
67960
Other (OTH)
AF:
0.391
AC:
826
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1662
3325
4987
6650
8312
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
540
1080
1620
2160
2700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.292
Hom.:
12345
Bravo
AF:
0.409
Asia WGS
AF:
0.482
AC:
1675
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
3.4
DANN
Benign
0.72
PhyloP100
-0.15
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs180552; hg19: chr10-117818842; API